Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial Academic Article uri icon

Overview

MeSH Major

  • Cerebral Revascularization
  • Moyamoya Disease
  • Pia Mater
  • Temporal Arteries

abstract

  • The criticism of the ARUBA trial is warranted, as our study found that treatment of unruptured brain AVMs has an acceptable safety profile when approached in a multidisciplinary manner at an experienced institution, using surgical resection as the primary treatment modality when applicable.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.wneu.2018.09.025

PubMed ID

  • 30218805

Additional Document Info